Section Arrow
Quote
KRSA.NASDAQ
- Korsana Biosciences, Inc.
Quotes are at least 15-min delayed:2026/10/26 18:39 EDT
After Hours
Last
 31.9899
-0.1001 (-0.31%)
Bid
22
Ask
31.99
High 32.09 
Low 31.27 
Volume 220 
Regular Hours (Closed)
Last
 32.09
+0.78 (+2.49%)
Day High 
32.425 
Prev. Close
31.31 
1-M High
37.265 
Volume 
230.50K 
Bid
22
Ask
31.99
Day Low
30.71 
Open
31.13 
1-M Low
29.03 
Market Cap 
1.43B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 32.58 
20-SMA 32.29 
50-SMA 30.85 
52-W High 59.36 
52-W Low 7.1862 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-7.07/-2.95
Enterprise Value
1.43B
Balance Sheet
Book Value Per Share
-1.39
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
2.07M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AZTRAzitra1.53+0.815+113.99%3.58PE
After Hours 1.34 -0.19 -12.42%
SNTISenti Biosciences Holdings Inc.0.1751-0.0133-7.06%-- 
After Hours 0.2605 +0.0854 +48.77%
SPRCSciSparc Ltd.1.29+0.2+18.35%0PE
After Hours 0.9164 -0.3736 -28.96%
VBIOValion Bio Inc.0.84-0.1-10.64%-- 
After Hours 0.7949 -0.0451 -5.37%
MRNAModerna198.85-1.25-0.62%-- 
After Hours 196.63 -2.22 -1.12%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Korsana Biosciences Inc is a biopharmaceutical company developing therapeutics to treat neurodegenerative diseases beginning with Alzheimer's disease (AD. The company's flagship product candidate, KRSA-028, is an anti-amyloid beta antibodythat combines the proprietary Therapeutic Targeting (THETA) platform with well-validated aspects from other anti-Ab products that have achieved regulatory approval or are in late-stage clinical trials.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.